Skip to content

Biohaven BHVN Return on assets

Return on assets at other companies

Eli Lilly logo
Eli LillyLLY
24.5%+10.1pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-36%+8.4pp
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-26.8%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-37.9%+0.7pp
uniQure logo
uniQureQURE
-30.2%-1.3pp
Roivant Sciences logo
Roivant SciencesROIV
-14.7%-15.2pp

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Calculated from Biohaven’s reported figures.

Based on trailing twelve months.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's return on assets?
Biohaven (BHVN) reported return on assets of -140% in Q1 2026.
How has Biohaven's return on assets changed year-over-year?
Biohaven's return on assets increased by 30.9% year-over-year, from -202.5% to -140%.
What is the long-term trend for Biohaven's return on assets?
Over 3 years (2022 to 2025), Biohaven's return on assets has grown at a -0.8% compound annual growth rate (CAGR), from -141.9% to -138.5%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.